Open AccessOutcome and surgical strategy in critical sites in cases of psuedomyxoma peritonei
Author(s) -
Ahmed M. Mahmoud,
Marwa M. Hussein,
Manar M. Moneer
Publication year - 2016
Publication title -
journal of egyptian national cancer institute/journal of the egyptian national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 22
eISSN - 2589-0409
pISSN - 1110-0362
DOI - 10.1016/j.jnci.2016.08.004
Subject(s) - medicine , pseudomyxoma peritonei , hyperthermic intraperitoneal chemotherapy , conventional pci , surgery , cohort , cytoreductive surgery , intraperitoneal chemotherapy , appendix , cancer , general surgery , ovarian cancer , paleontology , myocardial infarction , biology
For a long time peritoneal neoplasms were considered beyond surgical intervention and beyond cure, till the concept of cytoreductive surgery (CRS) and adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) was introduced. However this surgical intervention is technically demanding and associated with considerable postoperative morbidity.